Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dysferlinopathy in Iran: Clinical and genetic report.
Fatehi F, Nafissi S, Urtizberea JA, Blanck-Labelle V, Lévy N, Krahn M, Dbouk MB, Attarian S. Fatehi F, et al. Among authors: attarian s. J Neurol Sci. 2015 Dec 15;359(1-2):256-9. doi: 10.1016/j.jns.2015.11.009. Epub 2015 Nov 11. J Neurol Sci. 2015. PMID: 26671124
Motor unit number index (MUNIX) in patients with anti-MAG neuropathy.
Fatehi F, Delmont E, Grapperon AM, Salort-Campana E, Sévy A, Verschueren A, Boucraut J, Attarian S. Fatehi F, et al. Among authors: attarian s. Clin Neurophysiol. 2017 Jul;128(7):1264-1269. doi: 10.1016/j.clinph.2017.04.022. Epub 2017 May 9. Clin Neurophysiol. 2017. PMID: 28545015
The utility of motor unit number index: A systematic review.
Fatehi F, Grapperon AM, Fathi D, Delmont E, Attarian S. Fatehi F, et al. Among authors: attarian s. Neurophysiol Clin. 2018 Oct;48(5):251-259. doi: 10.1016/j.neucli.2018.09.001. Epub 2018 Oct 2. Neurophysiol Clin. 2018. PMID: 30287192 Review.
Expanding the importance of HMERF titinopathy: new mutations and clinical aspects.
Palmio J, Leonard-Louis S, Sacconi S, Savarese M, Penttilä S, Semmler AL, Kress W, Mozaffar T, Lai T, Stojkovic T, Berardo A, Reisin R, Attarian S, Urtizberea A, Cobo AM, Maggi L, Kurbatov S, Nikitin S, Milisenda JC, Fatehi F, Raimondi M, Silveira F, Hackman P, Claeys KG, Udd B. Palmio J, et al. Among authors: attarian s. J Neurol. 2019 Mar;266(3):680-690. doi: 10.1007/s00415-019-09187-2. Epub 2019 Jan 21. J Neurol. 2019. PMID: 30666435 Free PMC article.
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis.
Lingor P, Weber M, Camu W, Friede T, Hilgers R, Leha A, Neuwirth C, Günther R, Benatar M, Kuzma-Kozakiewicz M, Bidner H, Blankenstein C, Frontini R, Ludolph A, Koch JC; ROCK-ALS Investigators. Lingor P, et al. Front Neurol. 2019 Mar 27;10:293. doi: 10.3389/fneur.2019.00293. eCollection 2019. Front Neurol. 2019. PMID: 30972018 Free PMC article.
320 results